285 related articles for article (PubMed ID: 9415404)
1. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation.
Erenburg I; Schachter B; Mira y Lopez R; Ossowski L
Mol Endocrinol; 1997 Dec; 11(13):2004-15. PubMed ID: 9415404
[TBL] [Abstract][Full Text] [Related]
2. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
3. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor.
Zajchowski DA; Sager R
Mol Endocrinol; 1991 Nov; 5(11):1613-23. PubMed ID: 1664044
[TBL] [Abstract][Full Text] [Related]
4. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
5. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells.
deFazio A; Chiew YE; McEvoy M; Watts CK; Sutherland RL
Cell Growth Differ; 1997 Aug; 8(8):903-11. PubMed ID: 9269899
[TBL] [Abstract][Full Text] [Related]
6. The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.
Clarke R; Brünner N; Katz D; Glanz P; Dickson RB; Lippman ME; Kern FG
Mol Endocrinol; 1989 Feb; 3(2):372-80. PubMed ID: 2710138
[TBL] [Abstract][Full Text] [Related]
7. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
Levenson AS; Gehm BD; Pearce ST; Horiguchi J; Simons LA; Ward JE; Jameson JL; Jordan VC
Int J Cancer; 2003 May; 104(5):587-96. PubMed ID: 12594813
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha.
Liu S; Sugimoto Y; Kulp SK; Jiang J; Chang HL; Park KY; Kashida Y; Lin YC
Anticancer Res; 2002; 22(6C):3917-23. PubMed ID: 12553013
[TBL] [Abstract][Full Text] [Related]
10. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant.
Chaidarun SS; Swearingen B; Alexander JM
J Clin Endocrinol Metab; 1998 Sep; 83(9):3308-15. PubMed ID: 9745446
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines.
Cho HS; NG PA; Katzenellenbogen BS
Mol Endocrinol; 1991 Sep; 5(9):1323-30. PubMed ID: 1722871
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
14. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
[TBL] [Abstract][Full Text] [Related]
15. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
Martini PG; Katzenellenbogen BS
Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
Huo B; Dossing DA; Dimuzio MT
J Bone Miner Res; 1995 May; 10(5):769-81. PubMed ID: 7639112
[TBL] [Abstract][Full Text] [Related]
17. A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression.
Chaidarun SS; Alexander JM
Mol Endocrinol; 1998 Sep; 12(9):1355-66. PubMed ID: 9731704
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation.
Lazennec G; Alcorn JL; Katzenellenbogen BS
Mol Endocrinol; 1999 Jun; 13(6):969-80. PubMed ID: 10379895
[TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid.
Sheikh MS; Shao ZM; Chen JC; Hussain A; Jetten AM; Fontana JA
J Cell Biochem; 1993 Dec; 53(4):394-404. PubMed ID: 8300756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
